Supernus Pharmaceuticals Inc (SUPN)

Current ratio

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total current assets	US$ in thousands	686,070	493,113	734,151	601,590	630,417
Total current liabilities	US$ in thousands	292,397	290,196	687,958	315,379	245,108
Current ratio		2.35	1.70	1.07	1.91	2.57

December 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $686,070K ÷ $292,397K
= 2.35

The current ratio of Supernus Pharmaceuticals Inc has shown some fluctuations over the past five years. As of December 31, 2020, the current ratio was 2.57, indicating a healthy liquidity position with more than enough current assets to cover its short-term liabilities.

However, by December 31, 2022, the current ratio had decreased to 1.07, suggesting a potential strain on the company's ability to meet its short-term obligations with its current assets alone.

The ratio improved by December 31, 2023, reaching 1.70, indicating a slight recovery in liquidity. By December 31, 2024, the current ratio further increased to 2.35, signaling a stronger liquidity position compared to the previous year.

Overall, the trend in Supernus Pharmaceuticals Inc's current ratio indicates fluctuations in its liquidity position over the years, with improvements in recent periods. It is important for stakeholders to monitor this ratio to assess the company's ability to meet its short-term financial obligations.